Q32 Bio

Q32 Bio P/TBV

The Price to Tangible Book Value (P/TBV) of Q32 Bio (QTTB) as of Nov 21, 2026 is 8.45. In the previous year, Price to Tangible Book Value (P/TBV) was 0.66 — a change of 1,185.05% (higher).

P/TBV

8.45

YoY

1,185.05%

Last updated:

Price to Tangible Book Value (P/TBV) of Q32 Bio is 2024 8.45 . Price to Tangible Book Value (P/TBV) of Q32 Bio was 2023 0.66 . It decreases by 1,185.05% higher compared to the previous year.

The Q32 Bio P/TBV history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/TBV
Date
P/TBV
Jan 1, 2017
0.49 USD
Jan 1, 2018
0.24 USD
Jan 1, 2019
0.19 USD
Jan 1, 2020
0.24 USD
Jan 1, 2021
0.28 USD
Jan 1, 2022
0.27 USD
Jan 1, 2023
0.66 USD
Jan 1, 2024
8.45 USD
The Q32 Bio P/TBV history
YEARP/TBVYoY
8.45+1,185.05%
0.66+143.87%
0.27-4.66%
0.28+15.50%
0.24+31.89%
0.19-24.02%
0.24-49.95%
0.49-92.37%
6.40—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Q32 Bio Stock analysis

What does Q32 Bio do? Homology Medicines, Inc. generates revenue by developing and commercializing treatments for rare diseases at the genetic level. The company operates as a technology platform focused on creating a pipeline of new medicines that address and cure the underlying cause of monogenic diseases. Its lead product candidate, HMI-102, is a gene therapy designed for the treatment of phenylketonuria (PKU), with the PKU program specifically targeting adults using this gene therapy approach. The firm utilizes its suite of 15 adeno-associated virus vectors (AAVHSCs) to enable a method of gene editing called gene correction, allowing for precise targeting of disease-relevant tissues across both gene editing and gene therapy modalities. Q32 Bio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Q32 Bio stock

Price to Tangible Book Value (P/TBV) of Q32 Bio is 8.45 in 2024.

Price to Tangible Book Value (P/TBV) of Q32 Bio changed from 0.66 to 8.45, representing a 1,185.05% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Price to Tangible Book Value (P/TBV) Q32 Bio since 2006 – with annual values, charts, and detailed analysis.

P/TBV compares the stock price to tangible book value per share, excluding goodwill and intangibles. It provides a conservative asset-based valuation.

To evaluate Price to Tangible Book Value (P/TBV)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Price to Tangible Book Value (P/TBV).

A 'good' varies by industry and company stage. On Eulerpool, you can compare Price to Tangible Book Value (P/TBV)'s Q32 Bio with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Q32 Bio

All Key Metrics — Q32 Bio